News

The Physicians Committee for Responsible Medicine and InSphero are pleased to announce the winners of the HUMAIN Award 2023. The initiative recognizes researchers working to expand the access to and accelerate the uptake of human-specific non-animal approaches.

InSphero AG, the global leader in 3D cell culture technologies and organ-on-chip systems for drug discovery, and ATCC, the world’s premier biological materials management and standards organization, will work together to introduce new paradigms in the rapidly evolving field of 3D cell-based oncology research.

InSphero announces the launch of the MASH CALL Initiative for fast and reliable identification and comparison of therapeutic candidates for the clinical treatment of MASH.

InSphero Launches New Website Showcasing “The Model of Excellence™” Empowering Breakthroughs in 3D In Vitro Therapies

InSphero and Darwin Microfluidics signed distribution agreement to facilitate purchasing InSphero’s 3D in vitro products within the European Union Zurich, Switzerland – September 7, 2023

InSphero and Advanced BioMatrix signed a distribution agreement to expand the application range in 3D cell culture into scaffold-based models Zurich, Switzerland – August 8,

InSphero AG and Cosmo Bio Co., Ltd Enter into Strategic Partnership to Distribute InSphero’s Innovative Product Portfolio in Japan Zurich, Switzerland and Tokyo, Japan -

The Physicians Committee and InSphero Launch Award Program to Accelerate Adoption of Human In Vitro Models

InSphero and Bionova Supplies signed a distribution agreement to accelerate the development of spheroid and organoid cultures in India April 25, 2023 | Schlieren, Switzerland

Eurostars-funded REPRINT consortium reaches milestones with evidence of complete tumor regression induced by dendritic cell reprogramming Schlieren, Switzerland | 11 April 2023  InSphero announces today, together